VivoSeq
Other

Immune Function

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Immune Function is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed9 · 53%
Recruiting3 · 18%
Unknown status2 · 12%
Enrolling by invitation2 · 12%
Terminated1 · 6%

Trial Activity

17 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)